Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Lly source : Www.biospace.com save search
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
Published: 2024-04-17 (Crawled : 11:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 1.03%
H: 1.66%
C: -1.11%
obesity tirzepatide
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
announcement conference for financial results
Blacksmith Medicines To Highlight Preclinical Oncology Data Demonstrating a Potent and Selective FEN1 Inhibitor Has Synergy with Multiple DDR Drug Classes at AACR Annual Meeting 2024
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
drug preclinical meeting
The Top 11 Companies Hiring in Biopharma Now
Published: 2024-04-04 (Crawled : 05:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
companies biopharma
Blacksmith Medicines to Present at the 23rd Annual Needham Healthcare Conference
Published: 2024-04-03 (Crawled : 15:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
conference
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
Published: 2024-03-28 (Crawled : 12:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $4.135 3.63% 330K
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | News | $98.12 3.15% 1.1M
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | $14.355 1.81% 510K
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $9.68 9.3K
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
Published: 2024-03-26 (Crawled : 20:00) - biospace.com/
MURA | $3.6 0.28% 35K
|
|
| O: 3.7%
H: 2.57%
C: 0.22%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
medical therapeutics
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
Published: 2024-03-26 (Crawled : 11:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
expansion therapeutics
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
Published: 2024-03-20 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -0.35%
H: 0.4%
C: 0.36%
series therapeutics
Blacksmith Medicines to Present at the Gordon Research Conference on New Antibacterial Discovery and Development
Published: 2024-03-19 (Crawled : 15:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -0.55%
H: 2.03%
C: 1.89%
conference antibacterial research
Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP, FACP, to its Board of Directors
Published: 2024-03-14 (Crawled : 14:30) - biospace.com/
AMLX A | $2.005 1.26% 410K
|
|
| O: -1.45%
H: 0.04%
C: -6.49%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.94%
H: 0.4%
C: -0.55%
pharmaceuticals
MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -1.3%
H: 0.61%
C: -2.37%
business therapeutics
FDA Delays Approval of Donanemab for the Treatment of Early-Stage Alzheimer’sAgency to convene an advisory committee to consider the drug
Published: 2024-03-08 (Crawled : 15:30) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: -2.29%
fda drug approval treatment
The Top 12 Biopharma Companies Hiring Now
Published: 2024-03-06 (Crawled : 19:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.86%
H: 0.45%
C: -0.58%
companies biopharma
We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for ...
Published: 2024-02-22 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.59%
H: 1.11%
C: 0.92%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 2.37%
H: 1.51%
C: 0.79%
We Don’t Know What We Don’t Know: LGBTQIA+ Patient Data and the Struggle for Inclusivity
Published: 2024-02-22 (Crawled : 09:00) - biospace.com/
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.59%
H: 1.11%
C: 0.92%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 2.37%
H: 1.51%
C: 0.79%
Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
Published: 2024-02-21 (Crawled : 21:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
JAZZ | $110.11 1.18% 80K
|
Health Technology
|
| O: -0.12%
H: 1.79%
C: 1.75%
pharmaceuticals financial
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
UTHR | $237.975 1.67% 82K
|
Health Technology
|
| O: 2.59%
H: 3.66%
C: -0.24%
year corporation therapeutics financial results
Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023
Published: 2024-02-20 (Crawled : 17:00) - biospace.com/
MS | News 0 d | $92.74 0.71% 550K
|
Finance
|
| O: -0.65%
H: 0.64%
C: -0.69%
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 1.02%
H: 0.43%
C: -4.35%
biopharma market
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.